SJM
36
7
ROP
74
2
BRK.B
42
2
CPB
44
4
GWW
44
-2
MOS
29
7
AIV
60
2
UAL
38
4
CCL
50
3
CMA
40
3
ETR
52
6
R
63
3
SO
73
3
SEE
42
2
JWN
55
2
AMZN
61
-3
HP
37
3
CHK
12
9
RL
79
3
HOG
33
2
SJM
36
7
ROP
74
2
BRK.B
42
2
CPB
44
4
GWW
44
-2
MOS
29
7
AIV
60
2
UAL
38
4
CCL
50
3
CMA
40
3
ETR
52
6
R
63
3
SO
73
3
SEE
42
2
JWN
55
2
AMZN
61
-3
HP
37
3
CHK
12
9
RL
79
3
HOG
33
2
Financhill
Back

Pineapple Financial Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
13

PAPL
Pineapple Financial

Last Price:
0.90
Seasonality Move:
--
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
13
Pineapple Financial (PAPL) is a Sell

Is Pineapple Financial a Buy, Sell or Hold?

  • The current Pineapple Financial [PAPL] share price is $0.90. The Score for PAPL is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • PAPL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PAPL Stock Price Chart

What is Pineapple Financial's stock price today?

  • The Pineapple Financial share price today is $0.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PAPL is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

PAPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 31.89 Sell
Chaikin Money Flow: -13488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1 - 1.26) Sell
Bollinger Bands (100): (1.17 - 1.49) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

PAPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Sell
20-day SMA: 1.08 Sell
50-day SMA: 1.24 Sell
200-day SMA: 0 Buy
8-day EMA: 0.98 Sell
20-day EMA: 1.07 Sell
50-day EMA: 1.2 Sell
200-day EMA: 0.19 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Pineapple Financial Earnings Growth & PAPL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.00 per share, and an increase next year of $0.29 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Pineapple Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):